Illinois CancerCare- Ottawa — Ottawa, Illinois

Illinois CancerCare- Ottawa is a clinical research site located in Ottawa, Illinois, United States 61350.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Illinois CancerCare- Ottawa has participated in 1 clinical trials.

Therapeutic areas: BRAF V600E-mutant Metastatic Colorectal Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Illinois CancerCare- Ottawa?

Illinois CancerCare- Ottawa has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Illinois CancerCare- Ottawa conducted?

Illinois CancerCare- Ottawa has 1 clinical trials on record. Their work covers BRAF V600E-mutant Metastatic Colorectal Cancer.

Is Illinois CancerCare- Ottawa accredited by Crixeo Health?

Illinois CancerCare- Ottawa has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Illinois CancerCare- Ottawa?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.